Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study)

American Journal of Cardiology

Volumn 91, Issue 11, 2003, Pages 1311-1315

  Von Mühlen, Denise ^a   Langer, Robert D ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COVARIANCE; DIET RESTRICTION; DISEASE MARKER; DISEASE PREDISPOSITION; FATALITY; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; SEX RATIO; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 0037612332     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00319-9     Document Type: Article

References (26)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
2. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 161:2001;1413-1419.
3. Frost P.H., Davis B.R., Burlando A.J., Curb J.D., Stamler J., Guthrie G.P., Isaacsohn J.L., Wassertheil-Smoller S., Wilson A.C., Stamler J. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation. 94:1996;2381-2388.
4. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 276:1996;875-881.
5. Bush T.L., Barrett-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M., Tyroler H.A., Rifkind B.M. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the Lipid Research Clinics Program Follow-Up Study . Circulation. 75:1987;1102-1109.
6. Goldbourt U., Medalie J.H. High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli Ischemic Heart Disease Study. Am J Epidemiol. 109:1979;296-308.
7. Castelli W.P. Cardiovascular disease in women. Am J Obstet Gynecol. 158:1988;1553-1560.
8. Langer R.D., Klauber M.R., Criqui M.H., Barrett-Connor E. Exercise and survival in the very old. Am J Geriatr Cardiol. 3:1994;24-34.
9. National Heart and Lung Institute Lipid Research Clinics Program Laboratory Methods Committee. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. 2 Ed. Washington, DC: US Government Printing Office, DHEW publication No 75-628, 1974.
10. Bass K.M., Newschaffer C.J., Klag M.J., Bush T.L. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 153:1993;2209-2216.
11. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs D.R., Bangdiwala S., Tyroler H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:1989;8-15.
12. Criqui M.H. Triglycerides and ischemic heart disease. Atherosclerosis Rev. 22:1991;75-79.
13. Ballantyne C.M., Andrews T.C., Hsia J.A., Kramer J.H., Shear C. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels . Am J Cardiol. 88:2001;265-269.
14. Havel R.J., Rapaport E. Management of primary hyperlipidemia. N Engl J Med. 332:1995;1491-1498.
15. Denke M.A., Sempos C.T., Grundy S.M. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 154:1994;401-410.
16. Davidson M.H., Testolin L.M., Maki K.C., von Duvillard S., Drennan K.B. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Arch Intern Med. 157:1997;1186-1192.
17. Ashraf T., Hay J.W., Pitt B., Wittels E., Crouse J., Davidson M., Furberg C.D., Radican L. Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease. Am J Cardiol. 78:1996;409-414.
18. Williams P.T., Dreon D.M., Blanche P.J., Krauss R.M. Variability of plasma HDL subclass concentrations in men and women over time. Arterioscler Thromb Vasc Biol. 17:1997;702-706.
19. Marcovina S.M., Gaur V.P., Albers J.J. Biological variability of cholesterol, triglycerides, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem. 40:1994;574-578.
20. Pieper R.M., Arnett D.K., McGovern P.G., Shahar E., Blackburn H., Luepker R.V. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992; The Minnesota Heart Survey. Arch Intern Med. 157:1997;2326-2332.
21. Lemaitre R.N., Furberg C.D., Newman A.B., Hulley S.B., Gordon D.J., Gottdiener J.S., McDonald R.H., Psaty B.M. Time trends in the use of cholesterol-lowering agents in older adults. Arch Intern Med. 158:1998;1761-1768.
22. Sacks F.M., Handysides G.H., Marais G.E., Rosner B., Kass E.H. Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med. 146:1986;1573-1577.
23. Hubert H.B., Eaker E.D., Garrison R.J., Castelli W.P. Life-style correlates of risk factor change in young adults an eight-year study of coronary heart disease risk factors in the Framingham offspring . Am J Epidemiol. 125:1987;812-831.
24. Kuller L.H., Hulley S.B., LaPorte R.E., Neaton J., Dai W.S. Environmental determinants, liver function, and high density lipoprotein cholesterol levels. Am J Epidemiol. 117:1983;406-418.
25. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 273:1995;199-208.
26. Harrell F.E. Jr, Lee K.L., Pollock B.G. Regression models in clinical studies determining relationships between predictors and response . J Natl Cancer Inst. 80:1988;1198-1202.